Citation: | SHAO Bin, ZHANG Jie, LV Min, ZHU Yulin, YU Jing, JIANG Hanfang, REN Jun, SONG Guohong, ZHU Budong, CHE Li, JIA Jun, LIANG Xu, WANG Chaoying, YAN Ying, LIN Xiaolin, HUANG Xiaolei, YOU Miaoning, WANG Xiaoli, ZHOU Xinna, DI Lijun. Effects of High-dose Chemotherapy Supported by Autologous Peripheral Blood Stem Cell on Quality of Life of Advanced Breast Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 145-149. DOI: 10.3971/j.issn.1000-8578.2015.02.010 |
[1] |
Wilcken N, Dear R. Chemotherapy in metastatic breast cancer: a summary of all randomised trials reported 2000-2007[J]. Eur J Cancer, 2008, 44(15): 2218-25.
|
[2] |
Colomer R. Gemcitabine and paclitaxel in metastatic breast cancer: a review[J]. Oncology (Williston Park), 2004, 18(14 Suppl 12 ): 8-12.
|
[3] |
Nitz UA, Mohrmann S, Fischer J, et al. Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase Ⅲ trial[J]. Lancet, 2005, 366(9501): 1935-44.
|
[4] |
Biron P, Durand M, Roché H, et al. Pegase 03: a prospective randomized phase Ⅲ trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer[J]. Bone Marrow Transplant, 2008, 41(6): 555-62.
|
[5] |
Lotz JP, Curé H, Janvier M, et al. High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol[J]. Eur J Cancer, 2005, 41(1): 71-80.
|
[6] |
Crump M, Gluck S, Tu D, et al. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16[J]. J Clin Oncol, 2008, 26(1): 37 -43.
|
[7] |
Partridge AH, Bunnell CA, Winer EP. Quality of life issues among women undergoing high-dose chemotherapy for breast cancer[J]. Breast Dis, 2001, 14: 41-50.
|
[8] |
Buccheri G. Depressive reactions to lung cancer are common and often followed by a poor outcome[J].Eur Respir J, 1998, 11(1): 17 3-8.
|
[9] |
Brandberg Y, Michelson H, Nilsson B, et al. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401[J]. J Clin Oncol, 20 03, 21(19): 3659-64.
|
[10] |
Carlson LE, Koski T, Glück S. Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer[J]. Bone Marrow Transplant, 2001, 27(9): 989-98.
|
[11] |
Prieto JM, Atala J, Blanch J, et al. Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation[J].Bone Marrow Transplant, 2005, 35(3): 307-14.
|
[12] |
Andrykowski MA, Bishop MM, Hahn EA, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem cell transplantation[J]. J Clin Oncol, 2005, 23 (3): 599-608.
|
[13] |
Therasse P, Mauriac L, Welnicka-Jaskiewicz M, et al. Final results of a randomized Phase Ⅲ trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study[J]. J Clin Oncol, 2003, 21(5): 843-50.
|
[14] |
Morasso G, Costantini M, Baracco G, et al. Assessing psychological distress in cancer patients: validation of a self-administered questionnaire[J]. Oncology, 1996, 53(4): 295-302.
|
[15] |
Danaher EH, Ferrans C, Verlen E, et al. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant[J]. Oncol Nurs Forum, 2006, 33(3): 614-24.
|
[16] |
Yoo H, Lee K, Lee J, et al. Korean translation and validity of FACT-BMT version 4 and the quality of life in allogeneic bone marrow transplantation patients[J]. Qual Life Res, 2006, 15(3): 55 9-64.
|